CORESTEMCHEMON, Inc.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 2003-01-01
- Employees
- 378
- Market Cap
- -
- Website
- http://www.corestem.com
Clinical Trials
7
Active:1
Completed:6
Trial Phases
2 Phases
Phase 1:4
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (80.0%)Phase 3
1 (20.0%)Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS
Phase 1
Completed
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- First Posted Date
- 2024-11-06
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Corestemchemon, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT06676423
- Locations
- 🇰🇷
Hanyang university hospital, Seoul, Korea, Republic of
Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients with ALS
Phase 3
Active, not recruiting
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- First Posted Date
- 2021-02-09
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Corestemchemon, Inc.
- Target Recruit Count
- 115
- Registration Number
- NCT04745299
- Locations
- 🇰🇷
Pusan National University Yangsan Hospital, Yangsan, Kyungsangnam-do, Korea, Republic of
🇰🇷Korea University Anam Hospital, Seoul, Korea, Republic of
🇰🇷Hanyang university hospital, Seoul, Korea, Republic of
Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis
Completed
- Conditions
- Lupus Nephritis
- First Posted Date
- 2020-08-21
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Corestemchemon, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT04522505
- Locations
- 🇰🇷
Hanyang university hospital, Seoul, Korea, Republic of
Long-term Follow-up of Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101)
Completed
- Conditions
- Multiple System Atrophy
- First Posted Date
- 2020-08-03
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Corestemchemon, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT04495582
- Locations
- 🇰🇷
Yonsei University College of Medicine, Seoul, Korea, Republic of
Safety and Tolerability of CS10BR05 Inj. in Subjects with Multiple System Atrophy
Phase 1
Completed
- Conditions
- Multiple System Atrophy
- Interventions
- Biological: CS10BR05
- First Posted Date
- 2017-08-29
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Corestemchemon, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT03265444
- Locations
- 🇰🇷
Yonsei University College of Medicine, Seoul, Korea, Republic of
- Prev
- 1
- 2
- Next
News
No news found